The US Food and Drug Administration (FDA) has approved a new medical device, largely unremarkable but for one unusual aspect: It gives instructions to its administrator verbally. French life sciences ...
The US Court of Appeals for the First Circuit last week ruled that Sanofi improperly submitted a patent for its insulin device in the US Food and Drug Administration’s (FDA) Orange Book and could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results